Mosaic Immunoengineering Stock Today
| CPMV Stock | USD 0.76 0.06 8.57% |
PerformanceModest
| Odds Of DistressHigh
|
Mosaic Immunoengineerin is selling for under 0.76 as of the 22nd of March 2025; that is 8.57 percent increase since the beginning of the trading day. The stock's lowest day price was 0.76. Mosaic Immunoengineerin has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. The company was founded in 2020 and is based in Novato, California. The company has 7.24 M outstanding shares. More on Mosaic Immunoengineering
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Mosaic OTC Stock Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Mosaic Immunoengineering [CPMV] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mosaic Immunoengineerin's market, we take the total number of its shares issued and multiply it by Mosaic Immunoengineerin's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Mosaic Immunoengineering conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 7.24 M outstanding shares.
Mosaic Immunoengineering currently holds about 205.99 K in cash with (679.24 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check Mosaic Immunoengineerin Probability Of Bankruptcy
Ownership AllocationMosaic Immunoengineering secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.73 % of Mosaic Immunoengineering outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event.
Check Mosaic Ownership Details
Mosaic Immunoengineering Risk Profiles
| Mean Deviation | 7.02 | |||
| Semi Deviation | 8.99 | |||
| Standard Deviation | 14.32 | |||
| Variance | 204.99 |
Mosaic Stock Against Markets
Picking the right benchmark for Mosaic Immunoengineerin otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Mosaic Immunoengineerin otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Mosaic Immunoengineerin is critical whether you are bullish or bearish towards Mosaic Immunoengineering at a given time. Please also check how Mosaic Immunoengineerin's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Mosaic Immunoengineerin without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Mosaic Immunoengineerin Corporate Management
Elected by the shareholders, the Mosaic Immunoengineerin's board of directors comprises two types of representatives: Mosaic Immunoengineerin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mosaic. The board's role is to monitor Mosaic Immunoengineerin's management team and ensure that shareholders' interests are well served. Mosaic Immunoengineerin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mosaic Immunoengineerin's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jay Carlson | Sr Relations | Profile | |
| Steven King | Pres Chairman | Profile | |
| Cyril Empig | Head Devel | Profile | |
| Marvin MD | Head ImmunoOncology | Profile | |
| Nicole Steinmetz | Acting Director | Profile | |
| Paul CPA | CFO, VP | Profile | |
| Joseph MPH | Head Operations | Profile |
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.